Xiaoxu Li, Tingchao He, Sufang Duan, Jinghong Liang, Gang Feng, Fang Li, Zhenyu Shen, Wenhui Ye, Biao Liu, Bibo Jiang, Yujing Chen, Nan Liu, Ignatius Man-Yau Szeto, Li Cai
Despite the widely recommended usage of partially or extensively hydrolyzed milk protein formula (PHF or EHF) for preventing allergic diseases (ADs), clinical studies have been inconclusive regarding their efficacy compared with cow's milk formula (CMF) or breast milk (BM). We aimed to systematically evaluate the effects of PHF or EHF versus CMF or BM on the risk of ADs (cow's milk allergy, allergic rhinitis, eczema, asthma, wheeze, food allergy, and sensitization) in children. We searched PubMed, Embase, Cochrane Library, and Web of Science for clinical trials published from inception to October 21st, 2022...
April 3, 2024: Advances in Nutrition